Benjamin P. Howden
Impact in
- Clinical Biochemistry top 0.02%
- Bacterial Identification and Susceptibility Testing
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Bacterial Identification and Susceptibility Testing 90
-
- Antibiotic Resistance in Bacteria 55
- Co-authors
- Timothy P. StinearPaul D. R. JohnsonM. Lindsay GraysonTorsten SeemannJohn K. DaviesDeborah A. WilliamsonWei GaoPeter Ward
- Journals
- Antimicrobial Agents and Chemotherapy (25 papers)Microbial Genomics (18 papers)The Medical Journal of Australia (16 papers)Journal of Antimicrobial Chemotherapy (13 papers)Clinical Infectious Diseases (12 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Benjamin P. Howden
313 papers receiving 12.1k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Clinical Biochemistry 3.5k
- Molecular Medicine 2.0k
- Infectious Diseases 7.1k
- Applied Microbiology and Biotechnology 519
- Microbiology 1.3k
Countries citing papers authored by Benjamin P. Howden
This map shows the geographic impact of Benjamin P. Howden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin P. Howden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin P. Howden more than expected).
Fields of papers citing papers by Benjamin P. Howden
This network shows the impact of papers produced by Benjamin P. Howden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin P. Howden. The network helps show where Benjamin P. Howden may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Benjamin P. Howden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 23 | |
| 10 | 2020 | 38 | |
| 11 | 2019 | 10 | |
| 12 | 2019 | 65 | |
| 13 | 2019 | 27 | |
| 14 | 2019 | 14 | |
| 15 | 2018 | 128 | |
| 16 | 2017 | 10 | |
| 17 | 2016 | 29 | |
| 18 | 2014 | 11 | |
| 19 | 2011 | 39 | |
| 20 | Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications Hit paper breakdown → | 2010 | 720 |
About Benjamin P. Howden
Benjamin P. Howden is a scholar working on Clinical Biochemistry, Molecular Medicine, Infectious Diseases, Microbiology and Endocrinology, having authored 326 papers that have together received 12.4k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (138 papers), Bacterial Identification and Susceptibility Testing (90 papers), Bacterial biofilms and quorum sensing (65 papers), Antibiotic Resistance in Bacteria (55 papers), Streptococcal Infections and Treatments (30 papers), Reproductive tract infections research (26 papers), Salmonella and Campylobacter epidemiology (23 papers) and Genomics and Phylogenetic Studies (21 papers). The work is most often cited by research in Clinical Biochemistry (3.5k citations), Molecular Medicine (2.0k citations), Infectious Diseases (7.1k citations), Applied Microbiology and Biotechnology (519 citations) and Microbiology (1.3k citations). Benjamin P. Howden has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Timothy P. Stinear, Paul D. R. Johnson, M. Lindsay Grayson, Torsten Seemann, John K. Davies, Deborah A. Williamson, Wei Gao, Peter Ward, Glen P. Carter and M. Lindsay Grayson. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Microbial Genomics, The Medical Journal of Australia, Journal of Antimicrobial Chemotherapy and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.